Beneficial effects of the novel cholecystokinin agonist (pGlu-Gln)-CCK-8 in mouse models of obesity/diabetes
Irwin, N., Frizelle, P., Montgomery, I. A., Moffett, R. C., O’Harte, F. P. M., Flatt, P. R.
Published in Diabetologia (01.10.2012)
Published in Diabetologia (01.10.2012)
Get full text
Journal Article
Effects of first-line diabetes therapy with biguanides, sulphonylurea and thiazolidinediones on the differentiation, proliferation and apoptosis of islet cell populations
Sarnobat, D., Moffett, R. C., Flatt, P. R., Tarasov, A. I.
Published in Journal of endocrinological investigation (01.01.2022)
Published in Journal of endocrinological investigation (01.01.2022)
Get full text
Journal Article
Beneficial metabolic actions of a stable GIP agonist following pre-treatment with a SGLT2 inhibitor in high fat fed diabetic mice
Millar, P.J.B., Pathak, V., Moffett, R.C., Pathak, N.M., Bjourson, A.J., O'Kane, M.J., Flatt, P.R., Gault, V.A.
Published in Molecular and cellular endocrinology (15.01.2016)
Published in Molecular and cellular endocrinology (15.01.2016)
Get full text
Journal Article
Beneficial effects of parenteral GLP-1 delivery by cell therapy in insulin-deficient streptozotocin diabetic mice
Vasu, S, Moffett, R C, McCluskey, J T, Hamid, M H, Irwin, N, Flatt, P R
Published in Gene therapy (01.11.2013)
Published in Gene therapy (01.11.2013)
Get full text
Journal Article
Pharmacological characterization and antidiabetic activity of a long-acting glucagon-like peptide-1 analogue conjugated to an antithrombin III-binding pentasaccharide
Patterson, S., de Kort, M., Irwin, N., Moffett, R. C., Dokter, W. H. A., Bos, E. S., Miltenburg, A. M. M., Flatt, P. R.
Published in Diabetes, obesity & metabolism (01.08.2015)
Published in Diabetes, obesity & metabolism (01.08.2015)
Get full text
Journal Article